Spinal Tumors in Patients with Neurofibromatosis ...

4 downloads 77 Views 923KB Size Report
in 73 patients aged 4-69 years with NF2. The number, location, morphology, signal charac- teristics, and contrast medium uptake of the spinal tumors as seen.
951

Spinal Tumors Neurofibromatosis Imaging Study and Variety

Victor-Felix Mautner1 Marcos Tatagiba2 Matthias Lindenau1 Carsten F#{252}nsterer3 Stefan M. Pulst4 Lan Kluwe5 Friedhelm E. Zanella6

in Patients with Type 2: MR

of Frequency,

Multiplicity,

OBJECTIVE. Neurofibromatosis type 2 (NF2) is a rare autosomal dominant disorder leading to various tumors of the CNS, with vestibular schwannomas being the hailmark of the disease. We have observed multiple asymptomatic spinal lesions in patients who have a single symptomatic spinal tumor. Accordingly, we studied the frequency, multiplicity, and variety of spinal tumors in all patients with NF2 to determine what is characteristic of the disease. SUBJECTS AND METHODS. MR images of the entire spinal canal were made in 73 patients aged 4-69 years with NF2. The number, location, morphology, signal characteristics, and contrast medium uptake of the spinal tumors as seen on MR images were recorded and analyzed. Histopathologic proof of 22 spinal tumors was obtained in 1 9 patients. RESULTS. Spinal tumors were found on MR images in 89% of the patients studied. No location in any part of the spine was preferred. MR imaging showed intramedullary tumors in 24 patients (33%) (three ependymomas pathologically proven). Extradural and intradural extramedullary tumors were found on MR imaging in the cervical spine of 36 patients, the thoracic spine of 40 patients, and the lumbar spine of 49 patients. These tumors were meningiomas, schwannomas, or neurofibromas, three categories that could not be differentiated on the basis of the neuroradiologic findings, with ten schwannomas, seven meningiomas, and neurofibromas pathologically proven. Extradural extramedullary tumors were found on MR imaging in the cervical spine of 1 2 patients, the thoracic spine of five patients, and the lumbar spine of 1 8 patients. A syrinx associated with a tumor was found in patients. in 19 patients the variety of tumor types was confirmed by histologic examination. CONCLUSION. Patients with NF2 frequently have spinal tumors, which are often multiple and of various histologic types. The presence of multiple and different pathologic types of spinal tumors is highly suggestive of NF2.

two

two

Received January 3, 1995; accepted

after

revi-

sion May 8, 1995.

Supported by Hamburger Stiftung zur Forderung der Krebsbek#{228}mpfung(No. 116, 127) and the Wilhelm-Sander-Stiftung (93.05.21). 1Department

of Neurology.

Allgemeines

kenhaus Hamburg Ochsenzoll, Langenhorner Chaussee 560, 22419 Hamburg, Germany. Address correspondence to V-F. Mautner. 2

Department

kenhaus

of Neurosurgery,

Hannover,

Haltenhoffstr.

Nordstadtkran41

,

30167

Ha-

nover, Germany. 3 Hamburg-Othmarschen MRI Institute, Othmarscher Kirchenweg 166, 22763 Hamburg. Germany.

4Neurogenetics

Laboratory

and

Division

of

Neurology, Cedars-Sinai Medical Center, University of California at Los Angeles, 8700 Beverly Hills

Blvd., Los Angeles, CA 90048. 5Laboratory for Brain Tumor Biology, Neurosurgical Department, Universit#{228}tskrankenhaus Eppendorf, Martinistr. 52, 20246 Hamburg. Germany.

6Neuroradiology kum Essen,

Hufelandstr.

0361-803X/95/1654-951 © American Roentgen

Department, 55, 45122 Ray Society

Universit#{228}tskliniEssen,

AJR

1995;165:951-955

Kran-

Germany.

Neurofibromatosis type 2 (NF2) is a rare autosomal dominant disorder with an incidence of 1 :37,000 [1]. Its hallmark is the presence of bilateral vestibulan schwannomas. Additional manifestations include spinal tumors as well as brain tumors, peripheral nerve tumors, and cataracts [2]. The detection of multiple asymptomatic spinal lesions in patients with a symptomatic spinal tumor led to the assumption that spinal tumors are more common in patients with NF2 than has been assumed [3]. Confirmation of a high frequency of spinal tumors would show that such tumors are a criterion of the disease and aid in the diagnosis in family members and sporadic cases with suggested NF2. In order to determine the frequency, multiplicity, and vanety of spinal lesions in NF2, we analyzed spinal MR images of 73 patients with NF2.

Subjects

and

Methods

Patients with NF2 were through a neurofibromatosis

contacted treatment

departments

in search of patients with this disease.

were contacted

through patient workshops and publications and center. Additionally, some major neurosurgical

MAUTNER

952

The entire

spinal

canal

of 73 patients

years old) with a confirmed

diagnosis

imaging,

images

and

the

resulting

(38 male,

4-69 by MR

35 female,

of NF2 was examined were

analyzed.

In 68

patients,

are present or when there is a first-degree

at a young

age

[4]. The

remaining

five

relative with

patients,

who

did

not

meet the NIH criteria, were given the diagnosis of NF2 after the performance of mutation analysis or segregation analysis [5]. The radiologic diagnosis was based on the location of the tumor

(cervical,

thoracic,

position, logic

age

or lumbar spine), intramedullary

and

findings.

sex of the patient,

We

classified

tumors

and

previous

only

in general

or extramedullary radiologic

and

terms

of the

an analysis

na,

60

patients

tumors

44 patients intradural (Fig.

neuro-

as extradural

findings. only tumors greater than 0.4 cm in diameWe regarded five or more tumors in any part of the

which

dence defined

thoracic,

study,

one

or

Russel

or even

two

lumbar

and

spinal

tumors

of neurofibromatosis. multiplicity

region)

as

Rubinstein were

found

To differentiate

as the occurrence

multiple

[6] noted

in patients

from

of more

tumors.

several

than

with

histologic

had

of these

tumors

type.

(82%)

unproven)

were

found

to have

pathologically

proven

that were

extramedullary

and

classified could

be

or neurofibromas

tumors and

(with

19

the tumors

as extradural

of

and

either

meningiomas

(Figs.

2A and

2B).

none

pathologically

(Figs.

4A and 4B; with (11%) were thought (Fig.

proven),

5, Table

three

(4%)

had

ependymomas

all pathologically confirmed), and to have unclassifiable intramedul1 ; with

none

pathologically

proven).

in

no evi-

cases,

spinal

symptomatic

In a

cases

such four

clinically

examination

Of 24 patients (33%) with intramedullary tumors, 1 5 (21%) were thought to have astrocytomas (Figs. 3A and 3B; with

lary tumors

(cervical,

became

specific

1), schwannomas,

eight

pathologic

of their

of 16 patients

exclude nonspecific spine

who

the histologic

1995

MR imaging revealed spinal tumors in 65 (89%) of the 73 patients we examined. On the basis of our MR imaging cnite-

and intradural extramedullary tumors (meningiomas. schwannomas, and neurofibromas) and intramedullary tumors (astrocytomas, ependymomas, or unknown because of uncertainty of morphologic criteria). To ter were considered.

patients

of 22 operations;

October

Results

NF2 and either a unilateral 8th-nerve mass or a neurofibroma, meningioma, glioma, schwannoma, or posterior capsular cataract or opacity

AJR:165,

Nineteen

a total allowed

NF2 was diagnosed in accordance with the 1991 National Institutes of Health (NIH) criteria, according to which NF2 may be diagnosed when either bilateral 8th-nerve masses (seen by contrast-enhanced

MR imaging)

ET AL.

we

tumors.

(Note that the occurrence of various types of tumor at various locations results in percentages that do not add up to 100.) The examinations were performed between January 1991 and November 1994 using a 1.5-T Siemens Magnetom 63 SP scanner. Sagittal

and

weighted

coronal

sagittal

4-mm

images

slices

were

were

examined.

obtained.

Images

Tiwith

an

and echo

T2time

of 1 5-25 msec and a repetition time of up to 600 msec were regarded as Ti-weighted, and those with an echo time of between 80 and 120 msec and a repetition time of more than 2000 msec were regarded as T2-weighted. Ti-weighted coronal and sagittal images

were

mmol/kg images

prepared

or 0.2 were

and lumbar All MR

before

mI/kg

obtained

images, images

and

of gadopentetate with

a Helmholtz

with a circularly were

independently

after

IV

administration

dimeglumine. neck

polarized

coil,

assessed

behavior

before

and

after

administration

0.1

cervical

the

thoracic

coil.

by two

Tumors were assessed for their number, location, signal characteristics on the Ti - and T2-weighted signal

and

surface

of The

radiologists.

morphology, and images and for

of contrast

medium.

Fig. 1.-Histopathologicaliy proven meningiomas. 18-year-old man with pain radiating into right arm and diminished biceps jerk. Ti -weighted coronal MR image (SE 500/iS [TRITE]) shows two nodular extramedullary intradurally located tumors with foraminal involvement in C4-C5. Symptomatic spinal meningiomas at young age suggest neurofibromatosis type 2.

Fig. 2.-Histopathologicaiiy proven neurofibroma. 4-year-old boy presenting with tetraparesis. A, Ti-weighted sagittai MR image (SE 500/15 [TR/TE]) shows multinodular extramedullary tumor at C5-C6 compressing spinal cord. Variety of spinal tumors in neurofibromatosis type 2 inciudes neurofibromas. B, Ti-weighted axial image confirms cx-

trameduilary

location

of tumor (600/i 9).

AJR:165,

October

MR IMAGING

1995

Fig. 3.-Presumed

astrocytomas.

OF NEUROFIBROMATOSIS

SPINAL

TUMORS

953

31-year-

old woman with atactic gait disturbance. A, Ti-weighted coronal MR image(5E 500/15 [TR/TE]) shows three intramedullary masses

with intense

contrast

enhancement

centrally

and diffuse contrast enhancement peripherally. B, Ti-weighted sagittal MR Image (SE 500/ i5) confirms intrameduilary localization of contrast-enhancing tumors up to upper thoracic spine. Multiple Intramedullary tumors are teature of neurofibromatosis type 2.

Fig. 4.-Histopathoiogically

moma. 42-year-old pain.

proven

ependy-

woman with intractable

neck

A, Ti-weighted sagittal MR image (SE 500/15 [TR/TE]) after administration of contrast material shows intrameduilary tumor reaching from Ci to C4 with peripheral contrast enhancement and cystic tumor area reaching medulla oblon-

gata. Spinal ependymomas

belong to spectrum

of neurofibromatosis type 2. B, Flash two-dimensional MR image ent-recalied echo 340/18, 18 flip angle)

clear demarcation

(gradishows

of nodular Intramedullary

mor. Cranially and caudally, caplike mosiderin borders are visible.

black

tuhe-

TABLE i : Types bromatosis Type

of Tumors 2

Found

in 73 Patients

No. of Patients Type

with Neurofi-

with Spinal

of Tumor

Location

Tumors in Spine

All Regionsa

Intradural and extradural extramedullary tumors Intramedullary tumors Unknown Ependymoma/ astrocytoma

Fig. 5.-Intramedullary lesion of unknown type, no histopathologic 29-year-old man, clinically asymptomatic. Fast spin echo T2-weighted 91 [TR/TE])

sagittal

MR Image

of upper

thoracic

spine

shows

proof. (3500/ long extended

hyperintense intramedullary tumor with nodular structure (small amount of contrast enhancement in solid central parts of tumor is not shown here). Intramedullary tumors of unknown classification are part of variety in our series.

Thoracic

Lumbar

36

40

49

6 2

4 1

0 0

7

1

2 25

0 24

8(11%) 3(4%)

b

Astrocytomal ependymomac Syrinx No tumor aSums

60 (82%)

Cervical

i5(2i#{176}’o)

ii

2(3%) 8(11#{176}/o)

do not add up to 100#{176}o because

patient. bNo clear neuroradiologic cNo clear neuroradiologic

diagnosis. diagnosis.

0 26 multiple

tumors

may occur

most likely ependymoma. most likely astrocytoma.

in one

954

MAUTNER

Extra- and intramedullany tumors were not localized part of the spine. Thus, 47 patients (64%) were found at least one tumor in the cervical spine, 48 (66%) to least one tumor in the thomacic spine, and 49 (67%) at least one tumor in the lumbar spine. Twenty-four (33%) of the 73 patients were found intramedullary

tumors.

In the

cervical

part

of the

to any to have have at to have

operations

tion

showed

(22 operations three

tumors

in all). The to be ependymomas

histologic

tumors patients

AJR:165,

has not been with NF2.

Cumran

spinal

et al. [12]

elucidated

so far in a larger

series

of

a high frequency (26%) of in a kindred of 23 family mem-

documented

intramedullary

October 1995

tumors

11

examina-

(Figs.

seven to be meningiomas, ten to be schwannomas, two to be neurofibmomas (Table 2). The three patients clinically symptomatic tumors who did not have surgery thought to have astrocytomas. 7B),

AL.

to have cord,

patients were thought to have astrocytomas, six to have tumors that were unclassifiable on the basis of MR imaging criteria, and two to have ependymomas. The corresponding figures for the thoracic part of the cord were seven, four, and one, whereas in the conus medullamis one patient was thought to have an astrocytoma. In the case of two patients, an intramedullary tumor was accompanied by syningohydmomyelia (Table 1). Extramedullary tumors were found in the cervical spine in 36 patients, in the thoracic spine in 40 patients, and in the lumbar spine in 49 patients. Of these, extradunal tumors were found in the cervical spine in 12 patients, in the thoracic spine in five patients, and in the lumbar spine in 18 patients. Multiplicity of tumors was found in 41 patients (56%). Of these patients, 15 showed multiple tumors in the cervical spine (Fig. 6), 17 in the thoracic spine, and 37 in the lumbar spine (double counting possible). Two patients (3%) had multiple tumors in total, but not in any specific part of the spine. Twenty-two patients (30%) had less than five tumors in total and eight patients (11%) had no tumors. Twenty-two (30%) of the 73 patients had clinically symptomatic tumors. Sixteen of these patients subsequently had an operation, and three had two

ET

7A and

and with were

Fig. 6.-Multiple trast-enhanced

enhanced

Neumopathologic studies of cases with bilateral acoustic schwannoma revealed the association between the multiplicity of cranial and spinal meningeal, nerve sheath, and glial neoplasms and spinal tumors [7-11]. However, the significance of the frequency, multiplicity, and variety of spinal

MR image

intraspinal

tumors,

shows

evenly

proof.

and intensely

is significant

of 22 Tumors Type 2

28-

(500/15 [TRITE]) con-

tumors. Multiplicity

canal

TABLE 2: Histologic Findings tients with Neurofibromatosis

no histopathologic

Ti-weighted

multiple

extramedullary

lary tumors in one part of spinal matosis type 2.

contrast-

of extramedul-

finding

in neurofibro-

Removed

in 19 Pa-

No. of Tumors Type of Tumor

Location

All Regions

Intradural Discussion

extramedullary

year-old man, clinically asymptomatic.

in Spine

Cervical

Thoracic

10 7 2

2 3 2

3 4

3

2

Lumbar

and extradural

extramedullary

tumors

Schwannomas Meningiomas Neurofibromas Intramedullary

Ependymomas

5 -

-

-

tumors

1

-

Fig. 7.-Histologically proven ependymoma. 1 6-year-old boy with presenting symptom of tetraparesis at age of 10 years. A, Ti-weighted (680/25 [TR1TE]) contrast-enhanced MR image shows intensely enhanced tumor node 7 mm in size in region of medulla oblongata after operation on histopathologically proven ependymoma near craniocervical transition. The variety of spinal tumors in neurofibromatosis type 2 not only relates to histopathologic type but also to different age groups, especially children. The multiplicity of spinal tumors in neurofibromatosis type 2 may also relate to appearance of metastases in ependymoma. B, Ti -weighted (600/20) contrast-enhanced MR image shows multiple small contrast-enhancing tumor nodules in area of cauda equina. Suspected relapse of ependymoma with drop

metastases.

No histopathologic

proof.

MR IMAGING

AJR:165, October 1995

OF NEUROFIBROMATOSIS

SPINAL

TUMORS

955

bems affected by NF2. In a population-based study involving only partial examination ofthe spine in symptomatic patients, spinal tumors were found in 26% of the patients [13]. In a recent study by Parry et aI. [14], MR imaging of the entire spine was performed in 40 of 49 patients with NF2 and revealed spinal tumors in 30 patients (75%). Our MR imaging study confirms these observations in that 65 of 73 NF2 patients were found to have spinal tumors. Our results have some limitations, because our study was not population-based. Even assuming a referral bias, however, the finding that the proportion of patients with spinal tumors-especially with multiple tumors-is so high is clinically relevant in a number of ways. The frequency of spinal tumors in our study is similar to that of acoustic schwannomas in other studies (92% in Parry et al. [14]; 85% in Evans et al. [13]). The diagnostic value of spinal tumors for NF2 is thus similar to that of acoustic schwannomas and distinctly superior to that of some of the NIH diagnostic criteria, such as cataract or schwannomas of the skin on cranial nerves. Multiple spinal tumors should therefore be regarded as a hallmark of the disease [3]. The high frequency of spinal tumors in every part of the spine and the fact that we found no preferred localization of tumors in any part of the spine underscores the need to scan all parts of the spine in asymptomatic at-risk family membems. The occurrence of spinal tumors in different parts of the spine (22, on 30%, of our patients had less than five tumors in total) should immediately suggestthe differential diagnosis of NF2 besides familial meningioma [15], schwannomatosis [16], NFl [1 7], on metastatic dissemination in the CSF. A characteristic feature of the disease is the multiplicity of tumors in the spine. Parry et al. [14] found a mean number of 8.7 spinal tumors. However, this estimate was minimal, because tumors in some areas were too numerous to count. Our investigation confirmed the multiplicity of spinal tumors in 56% of the patients studied, with a predominance in the lumbar region (37%). In 15% of the patients with NF2 that Evans et al. studied, no vestibulam schwannomas were found, and at the time of the

Conclusion

screening,

13. Evans DGR, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. 0 J Med 1992:304:603-618

11%

of the

patients

were

found

to

be

clinically

asymptomatic [1 3]. Sporadic cases comprise one third to one half of NF2 patients [1], and segregation and direct mutation analysis is not effective in all patients [18, 19]. For this latter group of patients, MR imaging of the spine can identify NF2. MR imaging of the spine may also be particularly worthwhile in patients found to have a unilateral vestibulam schwannoma and multiple meningiomas on schwannomas of the other cranial nerves on the skin [20]. In such cases, MR imaging helps to confirm the provisional diagnosis of NF2 and thus permits appropriate genetic counseling of patients. In 22 histopathologically proven spinal tumors, schwannomas and meningiomas were the most common tumor types. Ependymomas, astrocytomas, and neumofibromas seem to be less common. This variety of tumor types seen in patients with NF2 is also characteristic of the disease.

The reader’s

attention

is directed

to the commentary

Spinal tumors occurring at a high frequency, multiplicity, and variety are a characteristic feature of NF2 and occur in symptomatic as well as in asymptomatic patients. The pmesence of multiple and different intraspinal tumors suggests NF2. The detection of spinal tumors in cases that do not satisfy the diagnostic criteria for NF2 may allow the diagnosis in at-risk family members and sporadic cases and thus permit appropriate genetic counseling.

REFERENCES i

.

Evans DG, Huson SM, Donnai D, et al. A genetic bromatosis in the United Kingdom. I. Prevalence,

and confirmation

study of type 2 neurofimutation rate, fitness effect on severity. J Med Genet

of matemal transmission

1992;29:841-846 2. Martuza RL, Eldridge R. Neurofibromatosis bromatosis). N EngI J Med 1988:318:684-688

2 (bilateral

acoustic

neurofi-

3, Mautner vF, Tatagiba M, Laute 5, Guthoff R, Samii M, Pulst SM. Clinical and genetic analysis of neurofibromatosis type 2 (abstr). Neurology 1992;42[suppl

3]:473

4. National Institutes of Health Consensus ment

Development

on Acoustic

Neuroma, December Panel. Arch NeuroIl994;51

11 -1 3, 1 991

Conference State. The Consensus

Development :201-207 5. Kluwe L, Pulst SM, KOppen J, Mautner VF. A 163-bp deletion at the C-terminus

of the schwannomin

gene

associated

with variable

phenotypes

of

neurofibromatosis type 2. Hum Genet 1995:95:443-446 6. Russel DS, Rubinstein U. Pathology oftumors of the nervous system, 5th ed. London:Arnold, 1989 7. Gerhardt G. Zur Diagnostik multipler Neurombildung. Deutsches Archly f#{252}r Kllnische

Medizin

1878;21

:269-298

8. Hirschberg

J. Stauungspapille durch heilkunde 1879;8:51-53 9. National Institutes of Health Consensus

Hirntumor.

Archiy

f#{252}r Augen-

Development Conference. Neu1988:45:575-580 10. Rubinstein U. The malformative central nervous system lesions in the central and peripheral forms of neurofibromatosis: a neuropathological study of 22 cases. Ann N YAcad Sci 1986:486:14-29 rofibromatosis:

11

.

conference

statement.

Wiestler OD, von Siebenthal bution and immunoreactivity

K, Schmitt HP, Feiden W, Kleihues P. Distriof cerebral micro-hamartomas in bilateral (neurofibromatosis 2). Acta Neuropathol

acoustic neurofibromatosis 1989:79:137-1 43 12.

14.

Arch Neurol

Curran JG, \Neissmann JR. Williams JP, Wertelecki W, Superneau DW. High incidence of spinal intramedullary tumor in a kindred affected by neurofibromatosis 2: MR findings (abstr). AJNR 1989:10:906

Parry

DM,

Eldridge

N. Neurofibromatosis viduals and clinical 450-461

R, Kaiser-Kupter

Ml, Bouzas

EA, Pikus

2 (NF2): Clinical characteristics evidence

for heterogeneity.

A, Patronas

of 63 affected mdi-

Am J Med Genet

1994:52:

15. Pulst SM, Rouleau GA, Marineau C, Fain P. Sieb JP. Familial meningioma is not allelic to neurofibromatosis 2. Neurology 1993:43:2096-2098 1 6. Viskochil D, Carey JC. Alternate and related forms of neurofibromatoses. In: Huson SM, Hughes RAC, eds. The neurofibromatoses: a pathogenetic and clinical oyerview. London: Chapmann & Hall, 1994:445-474 17. Egelhoff JC, Bates DJ, Ross JS, Rothner AD, Cohen BH. Spinal MR findings in neurofibromatosis type 1 and 2. Am J Neuroradioli992:13:1071-i 077 18. MacCollin M, Ramesh ‘I, Jacoby LB. et al. Mutational analysis of patients with NF2. Am J Hum Genet 1994:55:314-320 19. Merel P, Hoang-Xuan K, Sanson M, et al. Screening for germ-line mutations in the NF2 gene. Genes Chrom Cancer 1995:12:117-127

20. Mautner VF, Tatagiba M, Guthoff R, Samii M, Pulst SM. Neurofibromatosis 2 in the pediatric age group. Neurosurgery 1993:33:92-96

on this article,

which

appears

-

---

on the following

-- - -

1

pages.

-----

-